Beam Therapeutics Ownership | Who Owns Beam Therapeutics?
Beam Therapeutics Ownership Summary
Beam Therapeutics is owned by 98.86% institutional investors, 1.51% insiders. Farallon capital management is the largest institutional shareholder, holding 10.00% of BEAM shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 5.77% of its assets in Beam Therapeutics shares.
BEAM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Beam Therapeutics | 98.86% | 1.51% | -0.38% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Farallon capital management | 8.24M | 10.00% | $204.33M |
| Blackrock | 7.63M | 9.34% | $178.87M |
| Blackrock funding, inc. /de | 7.67M | 9.31% | $190.26M |
| Vanguard group | 7.62M | 9.25% | $189.03M |
| Ark investment management | 7.07M | 8.58% | $175.29M |
| Arch venture management | 4.54M | 5.51% | $112.60M |
| Nikko asset management americas | 3.96M | 4.80% | $98.11M |
| Sumitomo mitsui trust | 3.96M | 4.80% | $98.15B |
| Fmr | 3.32M | 4.03% | $82.27M |
| State street | 3.08M | 3.73% | $76.32M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mwg management | 2.27M | 75.61% | $56.22M |
| Arch venture management | 4.54M | 48.91% | $112.60M |
| Redmile group | 1.53M | 2.64% | $37.91M |
| Kynam capital management, lp | 1.76M | 2.57% | $43.55M |
| Casdin capital | 1.25M | 2.06% | $31.00M |
| Ark investment management | 7.07M | 1.46% | $175.29M |
| Nikko asset management americas | 3.96M | 1.06% | $98.11M |
| Farallon capital management | 8.24M | 1.04% | $204.33M |
| Bellevue group | 1.52M | 0.72% | $37.65M |
| Alphabet | 321.60K | 0.46% | $7.98M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 1.82M | 0.01% | 1.63M |
| Blackrock | 7.63M | 0.00% | 928.75K |
| Ark investment management | 7.07M | 1.46% | 536.93K |
| Casdin capital | 1.25M | 2.06% | 475.00K |
| Kynam capital management, lp | 1.76M | 2.57% | 454.07K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Morgan stanley | 803.83K | 0.00% | -3.32M |
| Darwin global management | - | - | -2.12M |
| Fmr | 3.32M | 0.00% | -894.22K |
| State street | 3.08M | 0.00% | -852.18K |
| Logos global management lp | - | - | -500.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Woodline partners lp | 282.12K | 0.05% | 282.12K | $7.00M |
| Point72 asset management | 193.36K | 0.01% | 193.36K | $4.80M |
| Cinctive capital management lp | 65.24K | 0.08% | 65.24K | $1.62M |
| Marshall wace, llp | 55.00K | 0.00% | 55.00K | $1.36M |
| Susquehanna fundamental investments | 52.73K | 0.02% | 52.73K | $1.31M |
Sold Out
| Holder | Change |
|---|---|
| Assetmark | -8.00 |
| Nelson, van denburg & campbell wealth management group | -14.00 |
| Northwestern mutual wealth management | -24.00 |
| Bessemer group | -35.00 |
| Advisornet financial | -45.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 237 | 3.95% | 81,473,315 | 3.08% | 98 | 1.07% | 120 | 17.65% | 65 | -1.52% |
| Sep 30, 2024 | 225 | 1.81% | 78,990,351 | 1.88% | 95 | 1.08% | 102 | -5.56% | 66 | 4.76% |
| Jun 30, 2024 | 219 | -6.01% | 77,530,743 | 10.73% | 94 | 1.15% | 107 | -21.90% | 62 | 31.91% |
| Mar 31, 2024 | 233 | 19.49% | 70,020,592 | 1.73% | 90 | 1.20% | 137 | 33.01% | 47 | -11.32% |
| Dec 31, 2023 | 195 | -2.50% | 68,827,655 | 2.56% | 87 | 1.13% | 103 | -7.21% | 53 | 26.19% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Disruptive Innovation Full Composite | 4.78M | 5.77% | 535.99K |
| ARK Innovation ETF | 5.56M | 5.56% | -53.24K |
| Vanguard Total Stock Mkt Idx Inv | 2.35M | 2.80% | 2.05K |
| Nikko AM ARK Disruptive Innovation A USD | 2.51M | 2.51% | 88.65K |
| iShares Russell 2000 ETF | 2.40M | 2.41% | -20.84K |
| Vanguard US Total Market Shares ETF | 2.33M | 2.34% | 2.59K |
| Vanguard Small Cap Index | 1.90M | 2.27% | 1.55K |
| ARK Genomic Revolution | 1.75M | 2.11% | -189.12K |
| ARK Genomic Revolution ETF | 1.97M | 1.98% | 76.09K |
| BB Biotech AG Ord | 1.52M | 1.83% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 01, 2025 | Bellon Christine | Chief Legal Officer | Sell | $104.12K |
| Apr 01, 2025 | Evans John M. | CEO | Sell | $562.68K |
| Apr 01, 2025 | Ciaramella Giuseppe | President | Sell | $136.42K |
| Apr 01, 2025 | Cavanagh Bethany J | SVP, Finance and Treasurer | Sell | $55.33K |
| Apr 01, 2025 | Simon Amy | Chief Medical Officer | Sell | $175.54K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2033 Q2 | - | - |
| 2024 Q4 | - | 2 |
| 2024 Q3 | - | 3 |
| 2024 Q2 | - | 7 |
| 2024 Q1 | - | 7 |
BEAM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools